NAF has launched a petition on Change.org calling on the FDA to prioritize treatment options for rare diseases with urgent unmet needs, including Spinocerebellar Ataxia (SCA).
SIGN THE PETITION

Day: July 10, 2025

NAF CEO Featured on Mission Matters Podcast

We’re excited to share that our CEO, Andrew Rosen, was recently featured on the Mission Matters podcast! In the episode, titled “Raising Awareness and Advancing Research,” Andrew discusses NAF’s commitment Read More…

Translate »

What is Ataxia?

Español

Educational Resources

Info by Ataxia Type

Info by Ataxia Type

Newly Diagnosed?

NAF Ataxia Research

NAF Funded Research by Year

Participate in Research

Learn About Research

Research Support

Drug Development Resources

Research Collaboration

Other Resources

Find Healthcare

Treatment Development

Support Groups

Connect

NAF Resources

Other Resources

Healthcare Provider Resources

Support NAF

Fundraise